In-depth guide

UPDATED FEB 2026

3M & DuPont PFAS Lawsuit

Part of the AFFF Firefighting Foam investigation

The short answer

3M and DuPont are the two primary defendants in the AFFF/PFAS litigation. 3M manufactured PFOS-based AFFF from the 1960s and has already paid $10.3 billion in water utility settlements and $850 million to Minnesota. DuPont manufactured PFOA and was the target of the landmark Bilott litigation that created the C8 Science Panel.

Internal documents from both companies show they knew about PFAS toxicity for decades and concealed it. Their corporate successors — Chemours, Corteva, and others — share in the liability.

People's Justice Research TeamUpdated February 20, 2026Fact-checked

Verified against court and regulatory records · No upfront fees · Your information is never sold

Free Case Review

Check your eligibility — free

Answer 2-3 quick questions to review your potential case.

Free · Confidential · About 2 minutes · A case specialist responds within 1 business day

Your answers are never sold or shared without your consent.

3M: The Primary AFFF Manufacturer

3M Company of Saint Paul, Minnesota was the primary manufacturer of PFOS-based AFFF from the 1960s through its voluntary production halt in 2000. 3M developed AFFF in partnership with the United States Navy, which mandated the foam's use at all military airfields. For nearly four decades, 3M was the dominant supplier of AFFF to the Department of Defense, commercial airports, industrial facilities, and municipal fire departments. The company's Scotchgard and other consumer products also contained PFAS, but AFFF was the largest single source of PFAS environmental contamination.

3M's internal knowledge of PFAS toxicity is extensively documented through litigation discovery. In the 1970s, 3M's own studies found PFAS in workers' blood at 1,000 times normal levels. Company toxicologists concluded that PFOA and PFOS "should be regarded as toxic." 3M hired Professor John Giesy to conduct research designed to keep the PFAS science "company-friendly." Despite knowing of the persistence, bioaccumulation, and toxicity of PFAS, 3M continued manufacturing and selling AFFF without warning users for another 24 years.

3M has paid enormous sums to resolve PFAS claims: $10.3 billion for water utility settlements (2023), $850 million to the State of Minnesota (2018), and additional amounts in smaller settlements. In 2023, 3M announced it would exit PFAS manufacturing entirely by the end of 2025 — a decision driven by the scale of litigation and regulatory liability. Despite these payments, the company's personal injury exposure in MDL 2873 remains substantial, with over 15,216 individual claims pending.

DuPont: The PFOA Story

E.I. du Pont de Nemours and Company — known simply as DuPont — manufactured PFOA (perfluorooctanoic acid) at its Washington Works facility in Parkersburg, West Virginia from the 1950s through 2015. DuPont used PFOA in the production of Teflon and other fluoropolymer products, and the chemical was released into the Ohio River and surrounding air, contaminating the drinking water of communities across the Mid-Ohio Valley for decades.

DuPont's concealment of PFOA toxicity is one of the most extensively documented cases of corporate malfeasance in environmental law. In 1980, two of eight pregnancies among PFOA-exposed workers resulted in birth defects — DuPont did not disclose this to regulators or workers. Throughout the 1990s, DuPont's animal studies showed PFOA caused tumors in laboratory rats — the company continued discharging PFOA into the environment. Attorney Robert Bilott's landmark litigation against DuPont, beginning with the Tennant case in 2001, forced the creation of the C8 Science Panel and exposed decades of corporate concealment.

DuPont has since restructured into three separate companies: DuPont de Nemours (the successor company), Chemours (spun off in 2015 to assume fluorochemical liabilities), and Corteva Agriscience (spun off in 2019). Together, these three entities settled water utility claims for $1.185 billion and previously settled approximately 3,550 C8 personal injury claims for $670.7 million. The corporate restructuring has been criticized as an attempt to isolate liabilities, but all three successor entities remain defendants in MDL 2873.

The combined liability of 3M, DuPont and its successors, and other AFFF manufacturers and distributors for personal injury claims represents one of the largest remaining exposures in environmental mass tort litigation. The evidence of corporate knowledge and concealment — spanning decades and documented through internal company records — provides the foundation for both compensatory and punitive damages claims.

Research & evidence

Scientific Evidence

meta-analysis

Meta-Analysis of PFAS Exposure and Cancer Risk: Kidney and Testicular Cancer

Mastrantonio M, Bai E, Uccelli R, Cordiano V, Screpanti A, Corigliano P. (2023). La Medicina del Lavoro

Key findings

  • Relative risk of 1.74 for kidney cancer among individuals with high PFAS exposure compared to low-exposure controls
  • Relative risk of 2.22 for testicular cancer among individuals with high PFAS exposure — the strongest relative risk of any PFAS-cancer association
  • Dose-response relationship demonstrated: higher PFAS blood levels correlated with progressively higher cancer risk
  • Results consistent across multiple study designs and populations, strengthening the causal inference
retrospective

"The Devil They Knew": Industry Knowledge of PFAS Dangers Since 1970

Brennan NM, Evans AT, Fritz MK, Peak SA, von Holst HE. (2023). Annals of Global Health

Key findings

  • PFAS manufacturers knew about the persistence and toxicity of their products as early as 1970 — more than 50 years before widespread public awareness
  • 3M conducted internal studies showing PFAS bioaccumulation in worker blood at 1,000 times normal levels and animal studies showing tumor formation, then classified results as confidential
  • Manufacturers used trade secret protections and proprietary research agreements to prevent damaging findings from reaching regulators or the public
  • The pattern of corporate concealment parallels the tobacco and asbestos industries and supports punitive damages claims based on willful and malicious conduct
cohort

C8 Science Panel: Probable Link Evaluations for PFOA-Associated Diseases

Fletcher T, Savitz D, Steenland K. (2012). Environmental Health Perspectives

Key findings

  • Determined "probable link" between PFOA exposure and six diseases: kidney cancer, testicular cancer, thyroid disease, ulcerative colitis, high cholesterol, and pregnancy-induced hypertension
  • Study population of 69,000 residents made it one of the largest PFAS health studies ever conducted, providing exceptional statistical power
  • Findings have been cited in virtually every subsequent PFAS lawsuit and regulatory action worldwide
  • The "probable link" standard — requiring more than just association but less than definitive proof — was a negotiated scientific threshold that has become the benchmark for PFAS causation evidence

FAQ

Frequently Asked Questions

36 QUESTIONS

The primary categories of eligible plaintiffs include: firefighters (municipal, airport, military, or industrial) who handled AFFF during training or fire suppression; military personnel stationed at bases where AFFF was used or stored (the DoD has identified 455+ contaminated installations); military families who lived on or near contaminated bases; community residents whose drinking water was contaminated by PFAS from nearby military bases, airports, or fire training facilities; and industrial workers at PFAS manufacturing plants. Linked conditions include kidney cancer, testicular cancer, thyroid disease, ulcerative colitis, liver damage, non-Hodgkin lymphoma, and high cholesterol. Attorneys handle these cases on contingency — fee terms vary by attorney.

Dive deeper

Related Guides

7 GUIDES

The full investigation

Part of the AFFF Firefighting Foam Investigation